A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
PHASE3
This study was a multicenter, randomized, double-blind, placebo-controlled ...
Status
Terminated
Location
University of South Alabama / Mitchell Cancer Institute Univ South AL
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
PHASE1
This phase I trial studies the side effects and best dose of combination ch...